Nuveen Asset Management, LLC Neurocrine Biosciences Inc Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 347,493 shares of NBIX stock, worth $40 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

347,493

Previous 357,194 2.72%

Holding current value

$40 Million

Previous $49.3 Million 2.89%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$130.86 - $143.19 $1.27 Million - $1.39 Million	-9,701 Reduced 2.72%	347,493 $47.8 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $434,101 - $478,510	-3,329 Reduced 0.92%	357,194 $49.3 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $481,027 - $602,066	-4,535 Reduced 1.24%	360,523 $47.5 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $3.84 Million - $4.79 Million	40,884 Added 12.61%	365,058 $41.1 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $7.2 Million - $8.43 Million	80,416 Added 32.99%	324,174 $30.6 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $382,368 - $499,830	-4,063 Reduced 1.64%	243,758 $24.7 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $3,415 - $4,065	-32 Reduced 0.01%	247,821 $29.6 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $638,504 - $747,985	-6,938 Reduced 2.72%	247,853 $26.3 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $419,042 - $553,287	5,529 Added 2.22%	254,791 $24.8 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $322,619 - $422,188	4,453 Added 1.82%	249,262 $23.5 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $2.68 Million - $3.58 Million	-33,700 Reduced 12.1%	244,809 $20.9 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $7.56 Million - $8.69 Million	-87,751 Reduced 23.96%	278,509 $26.7 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $7.52 Million - $8.6 Million	-84,124 Reduced 18.68%	366,260 $35.6 Million
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $1.39 Million - $1.9 Million	-15,901 Reduced 3.41%	450,384 $43.8 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $7.84 Million - $9.77 Million	-90,204 Reduced 16.21%	466,285 $44.7 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $3.18 Million - $4.47 Million	-33,108 Reduced 5.62%	556,489 $53.5 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $2.7 Million - $4.13 Million	-31,719 Reduced 5.11%	589,597 $71.9 Million
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $5.3 Million - $8.02 Million	-70,512 Reduced 10.19%	621,316 $53.8 Million
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $10.1 Million - $13.7 Million	-115,889 Reduced 14.35%	691,828 $74.4 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $3.43 Million - $4.16 Million	40,939 Added 5.34%	807,717 $72.8 Million
Q2 2019 Aug 15, 2019	BUY	$72.24 - $91.27 $55.4 Million - $70 Million	766,778 New	766,778 $64.7 Million

Others Institutions Holding NBIX

# of Institutions

641

Shares Held

95.3M

Call Options Held

661K

Put Options Held

227K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Neurocrine Biosciences Inc Transaction History